Remidio is an Indian MedTech firm specializing in ophthalmic solutions. By integrating AI and telemedicine into user-friendly diagnostic devices, Remidio is enables early detection of eye diseases like diabetic retinopathy and glaucoma. Its technology allows even non-specialists to conduct comprehensive eye tests, particularly in underserved regions.
Remidio is now planning to expand into global markets, with the support of visionary investors like Rajat Khare's Boundary Holding. Their investment underscores the growing confidence in MedTech’s potential to address critical healthcare challenges on a global scale.
Visit: https://garryongrowth.tumblr.c....om/post/767506112219
כמו
תגובה
לַחֲלוֹק
1 (877) 773-1002